期刊文献+

冠状动脉旁路移植术后高乳酸血症影响因素研究 被引量:3

A clinical research of factors relating to hyperlactatemia for post CABG patient
原文传递
导出
摘要 目的探讨冠状动脉旁路移植(CABG)术后患者发生高乳酸血症的影响因素,以及术后高乳酸血症与并发症、患者预后的关系。方法收集2016年3月至2016年10月CABG术后返ICU的1280例患者资料,根据术后是否出现高乳酸血症,分为高乳酸血症组(术后动脉血乳酸峰浓度≥3.0mmol/L,511例)和非高乳酸血症组(术后动脉血乳酸峰浓度〈3.0mmol/L,769例)。记录两组患者性别、年龄、相关病史、心功能等因素,对比术后肝肾功能、二次气管插管率、气管切开率、病死率、主动脉内球囊反搏(IABP)及体外膜肺氧合(ECMO)使用率、ICU停留和住院时间等。结果相较于非高乳酸血症组,高乳酸血症组术后二次气管插管率(P=0.003)和气管切开率(P=0.035)高,术后机械通气时间(P=0.009)长,住院病死率(P=0.000)高,ICU停留(P=0.039)及住院时间(P=0.047)长。多因素回归分析发现:术前应用IABP(P=0.040)、术后心源性休克(P=0.030)、术后发生急性肾损伤(AKI,P=0.020)和术后肝功能衰竭(P=0.039)是CABG患者术后发生高乳酸血症的独立危险因素;乳酸峰浓度时间〉30h(P=0.021)、术后发生AKI3期(P=0.030)、术后肝功能衰竭(P=0.025)和术后心源性休克(P=0.037)是CABG术后高乳酸血症患者住院死亡的独立危险因素。结论CABG术后持续性高乳酸血症患者病死率高,及时改善心脏等重要脏器功能并清除乳酸可降低病死率,改善患者预后。 Objective To research the factors relating to hyperlactatemia and its connections to certain combinations and the motality of post CABG patients. Methods Splitting the 1 280 cases of post OPCABG surgery patient admitted to ICU of Anzhen Hospital between March 2016 and October 2016 into two groups, including a hyperlactatemia group of 511 patients [ 340 males and 171 females, aged(63.81 _+ 9.1 )years ], and a none-hyperlactatemia group of 769 samples [ 499 males and 270 females, aged(61.72 + 8.97 ) years ]. Recording the pre-operative characteristics such as gender, age, medical history, heart function, and post-operative characteristics such as liver and kidney function, reintubation rate, tracheotomy treatment rate, mortality rate, IABP and ECMO usage rates, ICU and hospital stay time. Results As compare to the none-hyperlac- tatemia group, the hyperlactatemia group has : ( 1 ) higher reintubation rate ( P = 0. 003 ) and higher tracheotomy rate ( P = 0. 035 ) ; (2) longer mechanical ventilation time ( P = 0. 009) ; ( 3 ) higher mortality rate ( P = 0. 000) ; (4) longer ICU stay time (P = 0. 039) and hospital stay time( P = 0. 047 ). Multi factor regression discovered: pre-operative IABP( P = 0. 040 ), postoperative cadiogenic shock ( P = O. 030), post-operative AKI ( P = 0. 020), post-operative liver failure ( P = 0. 039) are the in- dependent risk factors for post-operative hyperlactatemia of CABG patient; peak lactate time 〉 30 h (P = 0. 021 ), post-opera- tive level 3 AKI ( P = 0. 030), post-operative liver failure ( P = 0. 025 ), post-operative cardiogenic shock ( P = 0. 037 ) are the independent risk factors for mortality of CABG post-operative hyperlactatemia patient. Condttsion After CABG operation, hyperlaetatemia patients had a higher mortality rate. Timely restoring heart and important organ function to remove lactate so to reduce mortality rate is advised.
作者 李菲 贾明 侯晓彤 Li Fei, Jia Ming, Hou Xiaotong(Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beifing 100029, Chin)
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2018年第3期161-164,共4页 Chinese Journal of Thoracic and Cardiovascular Surgery
关键词 高乳酸血症 冠状动脉分流术 预后 Hyperlactatemia Coronary artery bypass Prognosis
  • 相关文献

参考文献1

二级参考文献46

  • 1饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].中华肝脏病杂志,2006,14(2):154-156. 被引量:23
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 3Poison J, Lee WM, American Association for the Study of Liver Diseases. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 (5) : 1179-1197.
  • 4Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure : consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int, 2009, 3(1 ) : 269-282.
  • 5Lee WM, Stravitz RT, Larsin AM, et al. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology, 2012, 55 ( 3 ) : 965-967.
  • 6Deng G, Zhou G, Zhai Y, et al. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology, 2004, 40(2) :318-326.
  • 7Yan Z, Tan W, Xu B, et al. A cis-acting regulatory variation of estrogen receptor α ( ESR1 ) gene is associated with hepatitis B virus related liver cirrhosis. Hum Mutat, 2011,32 ( 10 ) : 1128-1136.
  • 8Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. Lancet, 2010, 376(9736) : 190-201.
  • 9Ostapowicz G, Fontana RJ, Schiaodt FV, et al. Results of a prospective study of acute liver failure at 17 teriary care centers in the United States. Ann Intern Med, 2002,137 (12) :947-954.
  • 10Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology, 2010, 51(6): 2117-2126.

共引文献274

同被引文献19

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部